Thank you for visiting Sunsho Pharmaceutical’s website and your interest in our firm.
Spring is here. The snow that fell in Tokyo in late March feels like an illusion. There are numerous locations to enjoy cherry blossoms in Fuji and Fujinomiya areas where our headquarters and many factories are based. Among them, the Fujisan Hongu Sengen Taisha Shrine is deeply connected to cherry blossoms because its deity, Konohananosakuyahime, has the phrase "konohana (a different way of calling cherry blossoms)" in her name. Unlike other parts of Japan, you can enjoy cherry blossoms for roughly one month by going to different places in this area. This is due to the significant elevation differences among the many locations as we’re literally on the base of Mr. Fuji. We especially recommend you visit our area during the cherry blossom season.
The current global economic landscape is expected to show resilient growth, driven by the ripple effects on the US economy where stable economic growth is expected due to robust domestic demand. However, depending on the impact of the current administration's aggressive policy management under their “America first” approach, Chinese economic trends and possibility of political instability in major European countries, growth could potentially slow down. Japan's economy is expected to gradually recover, backed by steady domestic demand due to wage increases, despite remaining uncertainties surrounding US policy management. On the other hand, we must remain cautious in the face of possible domestic political instability with the ruling party’s support declining, leading to House of Councilors (lower house) elections expected to take place this summer.
One year has passed since the “benikoji” or red yeast rice issue, which significantly undermined consumer trust in nutraceuticals. Discussions on regulatory revisions began thereafter, leading to efforts to ensure consumer safety and security. Although there are still no signs of a fundamental recovery in demand, it is essential for our industry to work on restoring trust in nutraceuticals that support "food and nutrition," which are vital to people's health. Sunsho Pharmaceutical in this regard, took the initiative to establish an industrial association in January 2025 solely for contract development manufacturing organizations (CDMO) in the nutraceuticals sector. Twenty-five like-minded companies, who put consumers first, have united to enhance safety and security of nutraceuticals from the consumer's perspective.
Our 33rd year began in April. We have a mission to “contribute to healthy minds and bodies of people around the world.” We will continue our evolution this year to remain the best partner to everyone collaborating with us. We look forward to working with everyone to fulfill our mission.
April 1, 2025
Row Imamura, CEO